首页> 外文期刊>Analytical and Bioanalytical Chemistry >Determination of non-steroidal anti-inflammatory drugs and their metabolites in milk by liquid chromatography–tandem mass spectrometry
【24h】

Determination of non-steroidal anti-inflammatory drugs and their metabolites in milk by liquid chromatography–tandem mass spectrometry

机译:液相色谱-串联质谱法测定牛奶中的非甾体类抗炎药及其代谢产物

获取原文
获取原文并翻译 | 示例
           

摘要

Non-steroidal anti-inflammatory drugs are widely used for treatment of animals. According to Council Directive 96/23/EC, residues of these drugs must be monitored because of the potential risk they pose to the consumers’ health. For this reason an LC–MS–MS method was developed for detection of wide range of NSAIDs, including both “acidic” NSAIDs (carprofen, diclofenac, flunixin, meloxicam, phenylbutazone, oxyphenbutazone, tolfenamic acid, mefenamic acid, naproxen, ketoprofen, ibuprofen, firocoxib, rofecoxib, and celecoxib) and “basic” NSAIDs (four metamizole metabolites). Analytes were extracted from milk samples with acetonitrile in the presence of ammonium acetate. One portion of the extract was directly analyzed for the presence of metamizole metabolites; a second portion was cleaned with an amino cartridge. All NSAIDs were separated on a Phenomenex Luna C8(2) column and analyzed by LC–MS–MS in negative (acidic NSAIDs) and positive (metamizole metabolites) ion modes. The method was validated in accordance with the requirements of Commission Decision 2002/657/EC. Within-laboratory reproducibility was in the range 7–28%, and accuracy was in the range 71–116%. The method enabled detection of all the analytes with the expected sensitivity, below the recommended concentrations. The method fulfills the criteria for confirmatory methods and, because of its efficiency, may also be used for screening purposes. The procedure was also successfully verified in the proficiency test organized by EU-RL in 2010. As far as the authors are aware, this is one of the first methods capable of detecting diclofenac residues below the MRL in milk (0.1 μg kg−1). An additional advantage is the possibility of simultaneous determination of “acidic” NSAIDs and metamizole metabolites.
机译:非甾体抗炎药被广泛用于治疗动物。根据理事会指令96/23 / EC,必须对这些药物的残留物进行监测,因为它们会对消费者的健康构成潜在的风险。因此,开发了一种LC-MS-MS方法,用于检测多种“ NSAID”,包括“酸性” NSAID(卡洛芬,双氯芬酸,氟尼辛,美洛昔康,苯基丁酮,羟苯丁酮,托芬那酸,甲芬那酸,萘普生,酮洛芬,布洛芬,非洛昔布,罗非昔布和塞来昔布)和“基本” NSAID(四种metamizole代谢物)。在乙酸铵存在下,用乙腈从牛奶样品中提取分析物。直接分析提取物的一部分是否存在咪唑代谢物;第二部分用氨基盒清洗。所有的NSAID在Phenomenex Luna C8(2)色谱柱上分离,并通过LC-MS-MS在负离子(酸性NSAIDs)和正离子(间苯二酚代谢物)离子模式下进行分析。该方法已根据委员会决议2002/657 / EC的要求进行了验证。实验室内的可重复性范围为7–28%,准确度为71–116%。该方法能够以低于建议浓度的预期灵敏度检测所有分析物。该方法满足确认方法的标准,并且由于其有效性,也可以用于筛选目的。该程序还在EU-RL于2010年组织的能力验证中得到了成功验证。据作者所知,这是能够检测牛奶中MRL以下(0.1μgkg -1 )。另一个优势是可以同时测定“酸性” NSAID和代谢产物代谢产物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号